Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2022
2023
2024
2025
Vivmark Residential (VMRK)
Price$65.35Cached quote
Net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2007
2008
2009
2010
2012
2013
2014
2015
2016
2017
2018
2019
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04B | $2.91B | $2.77B | $2.59B | — | — | $384,000 | $753,000 | $717,000 | $3.6M | $2.74B | $2.61B | $2.39B | $1.75B | $1.53B | $1.67B | $1.64B | $1.98B | $1.82B |
| Gross profit | $1.92B | $1.84B | $1.78B | $1.67B | — | — | — | — | — | — | — | — | — | — | — | $1.18B | $1.10B | $1.12B | — |
| Gross margin | 63.14% | 63.16% | 64.30% | 64.56% | — | — | — | — | — | — | — | — | — | — | — | 70.43% | 67.26% | 56.63% | — |
| Research & development | — | — | — | $16.6M | $3.2M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $1.02B | $961.8M | $926.7M | $872.3M | $850.6M | — | — | — | — | — | $1.74B | $1.69B | $1.88B | $1.23B | $1.12B | $1.33B | $1.21B | $694.9M | $1.33B |
| Operating income | $919.8M | $915.8M | $1.16B | $1.12B | $1.68B | $1.32B | $1.36B | $1.11B | $1.00B | $856.1M | $1.01B | $921.6M | $512.3M | $514.1M | $406.5M | $348.2M | $432.6M | $423.9M | $495.4M |
| Operating margin | 30.25% | 31.43% | 41.93% | 43.03% | — | — | 353,166.67% | 148,023.51% | 140,101.53% | 24,000.17% | 36.77% | 35.25% | 21.46% | 29.42% | 26.65% | 20.79% | 26.38% | 21.45% | 27.16% |
| EBITDA | $2.23B | $2.16B | $2.05B | $2.00B | $2.52B | $2.14B | $2.19B | $1.90B | $1.75B | $1.57B | $1.78B | $1.68B | $1.49B | $1.07B | $912.7M | $929.7M | $951.4M | $960.1M | $1.03B |
| EBITDA margin | 73.27% | 74.00% | 74.10% | 77.10% | — | — | 569,594.53% | 252,952.72% | 244,366.11% | 43,878.92% | 64.79% | 64.39% | 62.49% | 61.50% | 59.84% | 55.51% | 58.00% | 48.60% | 56.28% |
| Net income | $1.12B | $1.04B | $835.4M | $776.9M | $1.33B | $913.6M | $970.4M | $657.5M | $603.5M | $4.29B | $870.1M | $631.3M | $1.83B | $841.7M | $893.6M | $283.6M | $362.3M | $407.6M | $980.2M |
| Net profit margin | 36.84% | 35.55% | 30.18% | 29.96% | — | — | 252,702.34% | 87,322.05% | 84,163.74% | 120,329.77% | 31.70% | 24.14% | 76.67% | 48.17% | 58.59% | 16.93% | 22.09% | 20.63% | 53.74% |
| Basic EPSper basic share | $2.95 | $2.73 | $2.20 | $2.06 | $3.56 | $2.45 | $2.61 | $1.78 | $1.64 | $11.75 | $2.37 | $1.74 | $5.16 | $2.73 | $2.98 | $0.95 | $1.27 | $1.46 | $3.40 |
| Diluted EPSper diluted share | $2.94 | $2.72 | $2.20 | $2.05 | $3.54 | $2.45 | $2.60 | $1.77 | $1.63 | $11.68 | $2.36 | $1.73 | $5.16 | $2.71 | $2.98 | $0.95 | $1.27 | $1.46 | $3.40 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Brackenridge Alexander | 86K |
STERRETT STEPHEN E | 47.95K |
Parrell Mark J. | 47.34K |
Fenster Scott | 47.3K |
BYNOE LINDA | 46.51K |
Manelis Michael L | 45.03K |
HABEN MARY KAY | 36.69K |
Kaufman Ian | 30.28K |
Garechana Robert | 28.76K |
Carraway Catherine | 26.69K |
McLeod Bret | 26.4K |
SHAPIRO MARK S | 23.64K |
NEITHERCUT DAVID J | 20.23K |
Jones Nina P | 10.28K |
Hoff Ann | 10.08K |
Carr Chris | 2.97K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 18, 2026Form 4 | Manelis Michael LExecutive Vice President & COO | SellCommon Shares Of Beneficial Interest | 2.4K | $63.56 | $154.4K | 43.7K |
| Feb 18, 2026Form 4 | Kaufman IanChief Accounting Officer | SellCommon Shares Of Beneficial Interest | 909 | $63.56 | $57.8K | 29.4K |
| Feb 18, 2026Form 4 | Carraway CatherineEVP & CHRO | SellCommon Shares Of Beneficial Interest | 749 | $63.56 | $47.6K | 15.9K |
| Feb 10, 2026Form 4 | Manelis Michael LExecutive Vice President & COO | SellCommon Shares Of Beneficial Interest | 5.8K | $65.13 | $375.5K | 46.1K |
| Feb 10, 2026Form 4 | Garechana RobertEVP & Chief Investment Officer | SellCommon Shares Of Beneficial Interest | 3.6K | $65.13 | $236.9K | 18.7K |